Literature DB >> 23637398

Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution.

Jin Il Kim1, Ilseob Lee, Sehee Park, Min-Woong Hwang, Joon-Yong Bae, Sangmoo Lee, Jun Heo, Mee Sook Park, Adolfo García-Sastre, Man-Seong Park.   

Abstract

Influenza A virus has evolved and thrived in human populations. Since the 1918 influenza A pandemic, human H1N1 viruses had acquired additional N-linked glycosylation (NLG) sites within the globular head region of hemagglutinin (HA) until the NLG-free HA head pattern of the 1918 H1N1 virus was renewed with the swine-derived 2009 pandemic H1N1 virus. Moreover, the HA of the 2009 H1N1 virus appeared to be antigenically related to that of the 1918 H1N1 virus. Hence, it is possible that descendants of the 2009 H1N1 virus might recapitulate the acquisition of HA head glycosylation sites through their evolutionary drift as a means to evade preexisting immunity. We evaluate here the evolution signature of glycosylations found in the globular head region of H1 HA in order to determine their impact in the virulence and transmission of H1N1 viruses. We identified a polymorphism at HA residue 147 associated with the acquisition of glycosylation at residues 144 and 172. By in vitro and in vivo analyses using mutant viruses, we also found that the polymorphism at HA residue 147 compensated for the loss of replication, virulence, and transmissibility associated with the presence of the N-linked glycans. Our findings suggest that the polymorphism in H1 HA at position 147 modulates viral fitness by buffering the constraints caused by N-linked glycans and provide insights into the evolution dynamics of influenza viruses with implications in vaccine immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637398      PMCID: PMC3700310          DOI: 10.1128/JVI.00373-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

Review 2.  Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans.

Authors:  Leslie A Reperant; Thijs Kuiken; Albert D M E Osterhaus
Journal:  Vaccine       Date:  2012-04-24       Impact factor: 3.641

3.  Infection of human airway epithelium by human and avian strains of influenza a virus.

Authors:  Catherine I Thompson; Wendy S Barclay; Maria C Zambon; Raymond J Pickles
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Recommended composition of influenza virus vaccines for use in the 1998-1999 season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1998-02-27

5.  WHO influenza surveillance.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1996-11-22

6.  Recommended composition of influenza virus vaccines for use in the 1997-1998 season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-02-28

7.  Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.

Authors:  Taronna R Maines; Li-Mei Chen; Neal Van Hoeven; Terrence M Tumpey; Ola Blixt; Jessica A Belser; Kortney M Gustin; Melissa B Pearce; Claudia Pappas; James Stevens; Nancy J Cox; James C Paulson; Rahul Raman; Ram Sasisekharan; Jacqueline M Katz; Ruben O Donis
Journal:  Virology       Date:  2011-03-23       Impact factor: 3.616

Review 8.  Influenza: old and new threats.

Authors:  Peter Palese
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

9.  Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin.

Authors:  P C Roberts; W Garten; H D Klenk
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.

Authors:  W Gerhard; R G Webster
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  28 in total

1.  The anti-influenza virus effect of Phellinus igniarius extract.

Authors:  Sangmoo Lee; Jin Il Kim; Jun Heo; Ilseob Lee; Sehee Park; Min-Woong Hwang; Joon-Yong Bae; Mee Sook Park; Hyoung Jin Park; Man-Seong Park
Journal:  J Microbiol       Date:  2013-10-31       Impact factor: 3.422

2.  Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine.

Authors:  Hye-Lim Park; Seung-Hyun Shim; Eun-Young Lee; Whajung Cho; Sooho Park; Hyun-Jung Jeon; Sun-Young Ahn; Hun Kim; Jae-Hwan Nam
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

3.  DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.

Authors:  Jin Il Kim; Sehee Park; Sangmoo Lee; Ilseob Lee; Jun Heo; Min-Woong Hwang; Joon-Yong Bae; Donghwan Kim; Seok-Il Jang; Mee Sook Park; Man-Seong Park
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

4.  Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.

Authors:  Jin Il Kim; Sangmoo Lee; Gong Yeal Lee; Sehee Park; Joon-Yong Bae; Jun Heo; Hong-Youb Kim; Seok-Hun Woo; Hae Un Lee; Chung Am Ahn; Hye Jin Bang; Hyun Soo Ju; Kiwon Ok; Youngjoo Byun; Dae-Jin Cho; Jae Soo Shin; Dong-Yeon Kim; Mee Sook Park; Man-Seong Park
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

Review 5.  A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  J Mol Biol       Date:  2017-06-23       Impact factor: 5.469

6.  High accumulation in tobacco seeds of hemagglutinin antigen from avian (H5N1) influenza.

Authors:  Yanaysi Ceballo; Kenia Tiel; Alina López; Gleysin Cabrera; Marlene Pérez; Osmany Ramos; Yamilka Rosabal; Carlos Montero; Rima Menassa; Ann Depicker; Abel Hernández
Journal:  Transgenic Res       Date:  2017-10-06       Impact factor: 2.788

7.  Selection Pressure in the Human Adenovirus Fiber Knob Drives Cell Specificity in Epidemic Keratoconjunctivitis.

Authors:  Ashrafali M Ismail; Ji Sun Lee; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

8.  Multiscale Simulations Examining Glycan Shield Effects on Drug Binding to Influenza Neuraminidase.

Authors:  Christian Seitz; Lorenzo Casalino; Robert Konecny; Gary Huber; Rommie E Amaro; J Andrew McCammon
Journal:  Biophys J       Date:  2020-10-31       Impact factor: 4.033

Review 9.  Influenza Hemagglutinin Structures and Antibody Recognition.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Cold Spring Harb Perspect Med       Date:  2020-08-03       Impact factor: 5.159

10.  Full-Genome Sequence of a Reassortant H1N1 Swine Influenza Virus Isolated from Pigs in Italy.

Authors:  Chiara Chiapponi; Laura Baioni; Andrea Luppi; Ana Moreno; Alberto Castellan; Emanuela Foni
Journal:  Genome Announc       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.